Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Haupt Successfully Completes FDA Audits | Contract Pharma

What are you searching for?

Sign in
Breaking News

Haupt Successfully Completes FDA Audits

Four newly approved sites expand presence in U.S. market

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Haupt Pharma has successfully passed FDA inspections at four sites in Germany during the first half of 2012. The Haupt Pharma Group now has six facilities approved to manufacture drugs for the U.S. market. The company provides development and manufacturing services for both conventional drugs and various specialty products, including cytotoxics, hormones, betalactam antibiotics, and narcotics.
 
“These successful audits help the group to come much closer to its strategic goal of further expanding its presence in the U.S. market,” said Dr. Karl Heinz Brücher, chief operating officer of Haupt Pharma AG. “This result is an extremely positive signal to our customers and the market as it reflects both the exceptional performance and the high level of quality of our sites.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics